CompaniesTarix Pharmaceuticals

Tarix Pharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (9)
View all

Total Trials

9

As Lead Sponsor

8

As Collaborator

1

Total Enrollment

162

By Phase

PHASE2: 5PHASE1: 4

By Status

TERMINATED: 4WITHDRAWN: 3COMPLETED: 2
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT00757250
NCT00771810
NCT01121120
NCT01300611
NCT01554254
Hover over trial bars to see details

Recent Trials

NCT01882374Lead Sponsor
Efficacy Study of a TXA127 to Reduce Acute Graft-vs-Host Disease in Subjects Undergoing Double Umbilical Cord Blood Transplantation
PHASE2Withdrawn
Started: Dec 31, 2013 · Completed: Dec 31, 2013
NCT01882387Lead Sponsor
Efficacy Study of a TXA127 to Reduce Graft-vs-Host Disease in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation
PHASE2Withdrawn
Started: Dec 31, 2013 · Completed: Dec 31, 2013
NCT01554254Lead Sponsor
Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation
PHASE2Withdrawn
Started: Mar 31, 2012
NCT01362036Lead Sponsor
Phase I Study Evaluating TXA127 in Low/Intermediate-1 Risk Myelodysplastic Syndrome and Thrombocytopenia
PHASE1Terminated
2 participants
Started: Apr 30, 2011 · Completed: Apr 30, 2012
NCT01300611Lead Sponsor
TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation
PHASE1Terminated
20 participants
Started: Jan 31, 2011 · Completed: Dec 31, 2020
View all 9 trials →